218 related articles for article (PubMed ID: 28267398)
21. [Rare forms of the ductal carcinoma of the pancreas].
Setdikova GR; Filippova EM; Paklina OV; Kriger AG; Chekmareva IA; Gorin DS; Berelavichus SV; Bedin VV; Tavobilov MM
Khirurgiia (Mosk); 2013; (6):4-7. PubMed ID: 23887254
[TBL] [Abstract][Full Text] [Related]
22. The spectrum of histopathological changes encountered in pancreatectomy specimens after neoadjuvant chemoradiation, including subtle and less-well-recognised changes.
Kalimuthu SN; Serra S; Dhani N; Chetty R
J Clin Pathol; 2016 Jun; 69(6):463-71. PubMed ID: 26915370
[TBL] [Abstract][Full Text] [Related]
23. Cystic degeneration of ductal adenocarcinoma of the pancreatic tail.
H'ng MW; Kwek JW; Teo CH; Cheong DM
Singapore Med J; 2009 Mar; 50(3):e91-3. PubMed ID: 19352559
[TBL] [Abstract][Full Text] [Related]
24. Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine.
Di Franco G; Usai A; Funel N; Palmeri M; Montesanti IER; Bianchini M; Gianardi D; Furbetta N; Guadagni S; Vasile E; Falcone A; Pollina LE; Raffa V; Morelli L
World J Gastroenterol; 2020 Jun; 26(21):2792-2809. PubMed ID: 32550755
[TBL] [Abstract][Full Text] [Related]
25. Strategies to improve the outcome in locally advanced pancreatic cancer.
Späth C; Nitsche U; Müller T; Michalski C; Erkan M; Kong B; Kleeff J
Minerva Chir; 2015 Apr; 70(2):97-106. PubMed ID: 25658301
[TBL] [Abstract][Full Text] [Related]
26. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
Kenner BJ; Chari ST; Cleeter DF; Go VL
Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
[TBL] [Abstract][Full Text] [Related]
27. Intraductal papillary mucinous neoplasms of the pancreas.
Yeo CJ
Adv Surg; 2002; 36():15-38. PubMed ID: 12465545
[No Abstract] [Full Text] [Related]
28. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment.
Philip PA; Mooney M; Jaffe D; Eckhardt G; Moore M; Meropol N; Emens L; O'Reilly E; Korc M; Ellis L; Benedetti J; Rothenberg M; Willett C; Tempero M; Lowy A; Abbruzzese J; Simeone D; Hingorani S; Berlin J; Tepper J
J Clin Oncol; 2009 Nov; 27(33):5660-9. PubMed ID: 19858397
[TBL] [Abstract][Full Text] [Related]
29. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
30. Early detection of sporadic pancreatic cancer: summative review.
Chari ST; Kelly K; Hollingsworth MA; Thayer SP; Ahlquist DA; Andersen DK; Batra SK; Brentnall TA; Canto M; Cleeter DF; Firpo MA; Gambhir SS; Go VL; Hines OJ; Kenner BJ; Klimstra DS; Lerch MM; Levy MJ; Maitra A; Mulvihill SJ; Petersen GM; Rhim AD; Simeone DM; Srivastava S; Tanaka M; Vinik AI; Wong D
Pancreas; 2015 Jul; 44(5):693-712. PubMed ID: 25931254
[TBL] [Abstract][Full Text] [Related]
31. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
[TBL] [Abstract][Full Text] [Related]
32. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
World J Surg Oncol; 2019 Feb; 17(1):29. PubMed ID: 30736807
[TBL] [Abstract][Full Text] [Related]
33. TNFSF9 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Pancreatic Cancer.
Wu J; Wang Y; Jiang Z
J Gastrointest Cancer; 2021 Mar; 52(1):150-159. PubMed ID: 32077004
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic Cancer Early Detection and Interception in an Atypical Case of Peutz-Jeghers Syndrome.
Mork M; Quesada PR; Bannon S; Montiel MF; Fleming JB; Lynch PM; Bhutani MS; Lee JH; McAllister F
Pancreas; 2019 Apr; 48(4):e29-e30. PubMed ID: 30973470
[No Abstract] [Full Text] [Related]
35. [Pancreatic ductal adenocarcinoma].
Gallmeier E; Gress TM
Internist (Berl); 2018 Aug; 59(8):805-822. PubMed ID: 29980819
[TBL] [Abstract][Full Text] [Related]
36. [Pancreatic cancer- a curable disease].
Limani P; Samaras P; Lesurtel M; Graf R; DeOliveira ML; Petrowsky H; Clavien PA
Praxis (Bern 1994); 2015 Apr; 104(9):453-60. PubMed ID: 25900693
[TBL] [Abstract][Full Text] [Related]
37. Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis.
van Erning FN; Mackay TM; van der Geest LGM; Groot Koerkamp B; van Laarhoven HWM; Bonsing BA; Wilmink JW; van Santvoort HC; de Vos-Geelen J; van Eijck CHJ; Busch OR; Lemmens VE; Besselink MG;
Acta Oncol; 2018 Dec; 57(12):1655-1662. PubMed ID: 30264642
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic cancer and cancer screening programs: from nihilism to hope.
Pezzilli R; Corinaldesi R; Morselli-Labate AM
JOP; 2010 Nov; 11(6):654-5. PubMed ID: 21068511
[No Abstract] [Full Text] [Related]
39. TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis.
Crottès D; Lin YT; Peters CJ; Gilchrist JM; Wiita AP; Jan YN; Jan LY
Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13026-13035. PubMed ID: 31182586
[TBL] [Abstract][Full Text] [Related]
40. Prognostic stratification of resected pancreatic ductal adenocarcinoma: Past, present, and future.
Barhli A; Cros J; Bartholin L; Neuzillet C
Dig Liver Dis; 2018 Oct; 50(10):979-990. PubMed ID: 30205952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
